Cancer Letters
Volume 253, Issue 1 , Pages 115-123, 8 August 2007

Exploitation of drug-induced Bcl-2 overexpression for restoring normal apoptosis function: A promising new approach to the treatment of multidrug resistant cancer

  • Yaming Su

      Affiliations

    • Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA
  • ,
  • Xiaoping Zhang

      Affiliations

    • Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA
  • ,
  • Patrick J. Sinko

      Affiliations

    • Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA
    • The Cancer Institute of New Jersey, New Brunswick, NJ, USA
    • Corresponding Author InformationCorresponding author. Address: Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA. Tel.: +1 732 445 3831x213; fax: +1 732 445 4271.

Received 28 September 2006; received in revised form 16 January 2007; accepted 18 January 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was support by The Parke-Davis Endowed Chair in Pharmaceutics and Drug Delivery and NIH AI51214.

PII: S0304-3835(07)00031-6

doi:10.1016/j.canlet.2007.01.018

Cancer Letters
Volume 253, Issue 1 , Pages 115-123, 8 August 2007